The first LDN psoriasis pilot started in Glasgow yesterday. The plan is to recruit ten subjects who will receive LDN for three months. The first two patients were inducted into the trial at The Essential Health Clinic in Glasgow on the 10th December. It is hoped that the trial will be completed in time to be presented at the Conference in April in Glasgow. There are almost 1million psoriasis sufferers in the UK and 125 million worldwide. Although there are now some very effective treatments for severe psoriasis, the vast majority of patients do not qualify for this sometimes toxic treatment. There is a clear gap in the treatment provision for a non toxic oral treatment which could be LDN.

Share/Save/Bookmark